-
Current recommendations for stroke prophylaxis with warfarin for patients with atrial fibrillation do not take into account the risks of hemorrhage. Thus, Singer et al from Kaiser Permanente studied more than 13,000 patients with non-valvular atrial fibrillation to estimate the net clinical benefit of warfarin therapy for atrial fibrillation (reduction in thromboembolism minus the increase in intracranial hemorrhage).
-
Dual antiplatelet therapy with aspirin and clopidogrel has become the standard of care for patients suffering an acute coronary syndrome (ACS). However, there remains a significant incidence of recurrent ACS and mortality even in patients treated with dual antiplatelet therapy. Furthermore, clopidogrel is an irreversible platelet inhibitor, and patients requiring urgent surgery are at higher risk of bleeding if operated on within 5-7 days of clopidogrel use.
-
A witch's brew of apathy, fear, and misinformation about the H1N1 influenza A vaccine may cause considerable toil and trouble for clinicians responding to the first pandemic in four decades.
-
How difficult is it going to be to get people vaccinated against H1N1 pandemic influenza A?
-
In response to rumors about the safety of the 2009 H1N1 pandemic influenza A vaccine, federal public health officials have addressed the following myths and errors about the current situation:
-
A coalition of unions and occupational health and safety professionals has called on New York state health commissioner Richard F. Daines to withdraw the emergency regulation that requires all health care workers to receive flu vaccinations by Nov. 30.
-
One of infection prevention's true originals â in every sense of the term â Eddie Hedrick, BS, MT(ASCP), CIC, currently is emerging infections coordinator at the Missouri Department of Health and Senior Services in Jefferson City.
-
-
Long known to open a few doors, cold hard cash may now bring down walls as well.
-
To begin an ongoing journey to prevent health care-associated infections, Orlando-based Florida Hospital's clinical excellence team asked staff what risks they saw.
